XORTX Therapeutics

XRTXNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.686 M

$2.13 +4.93%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#481InMed PharmaceuticalsINM$4.12M
#482SciSparcSPRC$3.97M
#483XORTX TherapeuticsXRTX$3.69M
#484RedHill BiopharmaRDHL$3.68M
#485OnconetixONCO$3.29M

Where these numbers come from

Share counts and financials for XORTX Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.